Medical
Opentrons Labworks, which makes laboratory robots, said it raised $40 million in a Series E round led by healthcare investor Avego, with BroadOak Capital Partners also investing.
A dated step forward on the record · Company-reported
What the source says
“has announced a $40 million Series E financing led by healthcare investor Avego, with additional investment from BroadOak Capital Partners.”
What it means
Funding is the only milestone on Opentrons Flex's record, and it does not move the robot up the ladder. It stays at stage 1, Demo only. That sits oddly beside the company's own claims: it says more than 11,000 robots are in labs worldwide and that the Flex is on sale in its online shop. The record holds no named customer or paid deployment to back those claims, so the stage may understate the real position. Every other robot in Surgical and medical sits at stage 5.
Opentrons Flex, from Opentrons Labworks, is at stage 1 of 5 on our ladder: demo only. Its stage is set by other milestones on its record; this one adds to the history. This line rests on the company's own announcement; no regulator, customer or independent report confirms it in our sources yet.
Human help: The maker hasn't said whether people help it remotely.
Written with AI from our record of Opentrons Flex and checked against it: every figure appears in that record.
